Research
Vaccines could be a new frontier in KRAS targeting
Nature · By Hari Venkatesh Pai ·
The Brief
- A Nature Medicine article published online 13 November 2026 discusses KRAS-targeting vaccination as a potential approach to preventing pancreatic cancer recurrence.
- The piece states that a convergence of therapeutic and technological advances makes this approach plausible.
- The article notes that many hurdles remain before such vaccines could be used.
Why it matters
KRAS is a frequently mutated driver in pancreatic cancer, so a vaccine approach aimed at preventing recurrence would be a new direction for researchers and clinicians working on this disease.
Who’s affected
- cancer researchers and oncologists
- vaccine developers and immunotherapy researchers
Nature Medicine, Published online: 13 November 2026; doi:10.1038/s41591-026-04772-1 A convergence of therapeutic and technological advances reveals KRAS-targeting vaccination as a potential new approach to preventing the recurrence of pancreatic cancer, but many hurdles remain.
Timeline
Article published online in Nature Medicine (doi:10.1038/s41591-026-04772-1)
nature.com
Vaccines could be a new frontier in KRAS targeting